Use of Vasopressin in Neonatal Hypertrophic Obstructive Cardiomyopathy: Case Series

Overview

Journal J Perinatol

Specialty Gynecology & Obstetrics

Date 2020 Sep 20

PMID 32951013

Citations 5

Authors

Stephanie M Boyd

Kristin L Riley

Regan E Giesinger

Patrick J McNamara

Affiliations

Soon will be listed here.

Abstract

Objective: To determine the effect of vasopressin on arterial blood pressure in infants with neonatal hypertrophic obstructive cardiomyopathy (HOCM).

Study Design: Retrospective case study in Neonatal ICU involving six infants; five born to mothers with diabetes mellitus (mean gestational age 37.5 ± 0.9 weeks). Vasopressin infusion was started at a mean dose of 0.3 ± 0.2 mU/kg/min.

Result: Initiation of vasopressin was followed by improved mean (p = 0.004), systolic (p = 0.028), and diastolic (p = 0.009) arterial pressure within 2 h. Heart rate (p = 0.025) and oxygen requirement (p = 0.021) also declined after initiation. Serum sodium declined initially and recovered by 72 h (p = 0.017).

Conclusion: Although there is limited experience with vasopressin use in neonatal HOCM, our case series suggests it may be beneficial for improving systemic hypotension and stabilization of hemodynamics. The potential for hyponatremia is high, necessitating careful fluid/electrolyte management. A prospective randomized trial is necessary to confirm safety and efficacy of vasopressin treatment in neonatal HOCM.

Citing Articles

Tailored Therapies for Cardiogenic Shock in Hypertrophic Cardiomyopathy: Navigating Emerging Strategies.

Zakynthinos G, Gialamas I, Tsolaki V, Pantelidis P, Goliopoulou A, Gounaridi M J Cardiovasc Dev Dis. 2024; 11(12).

PMID: 39728291 PMC: 11678468. DOI: 10.3390/jcdd11120401.

Serum Sodium Concentration During Arginine Vasopressin Infusion in Critically Ill Children.

Muff R, Gotta V, Jaeggi V, Schlapbach L, Baumann P Children (Basel). 2024; 11(11).

PMID: 39594934 PMC: 11592650. DOI: 10.3390/children11111359.

Potential Therapeutic Targets for Hypotension in Duchenne Muscular Dystrophy.

Saxena H, Weintraub N, Tang Y Med Hypotheses. 2024; 185.

PMID: 38585412 PMC: 10993928. DOI: 10.1016/j.mehy.2024.111318.

New insights in pediatrics in 2021: choices in allergy and immunology, critical care, endocrinology, gastroenterology, genetics, haematology, infectious diseases, neonatology, neurology, nutrition, palliative care, respiratory tract illnesses and....

Caffarelli C, Santamaria F, Piro E, Basilicata S, Delle Cave V, Cipullo M Ital J Pediatr. 2022; 48(1):189.

PMID: 36435791 PMC: 9701393. DOI: 10.1186/s13052-022-01374-8.

Efficacy and Safety of Vasopressin and Terlipressin in Preterm Neonates: A Systematic Review.

Al-Saadi A, Sushko K, Bui V, van den Anker J, Razak A, Samiee-Zafarghandy S Int J Environ Res Public Health. 2022; 19(21).

PMID: 36360641 PMC: 9658127. DOI: 10.3390/ijerph192113760.

References

Zielinsky P, Piccoli Jr A . Myocardial hypertrophy and dysfunction in maternal diabetes. Early Hum Dev. 2012; 88(5):273-8. DOI: 10.1016/j.earlhumdev.2012.02.006. View

Halliday H . Hypertrophic cardiomyopathy in infants of poorly-controlled diabetic mothers. Arch Dis Child. 1981; 56(4):258-63. PMC: 1627227. DOI: 10.1136/adc.56.4.258. View

Mormile R . Neonates of diabetic mothers: The starting point for developing novel therapeutic approaches to ischemic heart and brain?. Med Hypotheses. 2016; 96:75-77. DOI: 10.1016/j.mehy.2016.09.009. View

Franzese A, Valerio G, Ciccarelli N, De Filippo G, Iannucci M, Alfonsi L . Severe hypertrophic cardiomyopathy in an infant of a diabetic mother. Diabetes Care. 1997; 20(4):676-7. DOI: 10.2337/diacare.20.4.676. View

Robinson B, Eshaghpour E, Ewing S, Baumgart S . Hypertrophic obstructive cardiomyopathy in an infant of a diabetic mother: support by extracorporeal membrane oxygenation and treatment with beta-adrenergic blockade and increased intravenous fluid administration. ASAIO J. 1998; 44(6):845-7. View

Way G, Wolfe R, Eshaghpour E, Bender R, Jaffe R, Ruttenberg H . The natural history of hypertrophic cardiomyopathy in infants of diabetic mothers. J Pediatr. 1979; 95(6):1020-5. DOI: 10.1016/s0022-3476(79)80302-9. View

Ullmo S, Vial Y, Di Bernardo S, Roth-Kleiner M, Mivelaz Y, Sekarski N . Pathologic ventricular hypertrophy in the offspring of diabetic mothers: a retrospective study. Eur Heart J. 2006; 28(11):1319-25. DOI: 10.1093/eurheartj/ehl416. View

Al-Biltagi M, Tolba O, Rowisha M, Mahfouz A, Elewa M . Speckle tracking and myocardial tissue imaging in infant of diabetic mother with gestational and pregestational diabetes. Pediatr Cardiol. 2014; 36(2):445-53. DOI: 10.1007/s00246-014-1033-0. View

McMahon J, Berry P, JOFFE H . Fatal hypertrophic cardiomyopathy in an infant of a diabetic mother. Pediatr Cardiol. 1990; 11(4):211-2. DOI: 10.1007/BF02238369. View

10.

Goldberg J, Mery C, Griffiths P, Parekh D, Welty S, Bronicki R . Extracorporeal membrane oxygenation support in severe hypertrophic obstructive cardiomyopathy associated with persistent pulmonary hypertension in an infant of a diabetic mother. Circulation. 2014; 130(21):1923-5. DOI: 10.1161/CIRCULATIONAHA.114.010678. View

11.

Giesinger R, McNamara P . Hemodynamic instability in the critically ill neonate: An approach to cardiovascular support based on disease pathophysiology. Semin Perinatol. 2016; 40(3):174-88. DOI: 10.1053/j.semperi.2015.12.005. View

12.

Holmes C, Landry D, Granton J . Science Review: Vasopressin and the cardiovascular system part 2 - clinical physiology. Crit Care. 2004; 8(1):15-23. PMC: 420051. DOI: 10.1186/cc2338. View

13.

HOLMES C, Patel B, Russell J, Walley K . Physiology of vasopressin relevant to management of septic shock. Chest. 2001; 120(3):989-1002. DOI: 10.1378/chest.120.3.989. View

14.

Mertens L, Seri I, Marek J, Arlettaz R, Barker P, McNamara P . Targeted neonatal echocardiography in the neonatal intensive care unit: practice guidelines and recommendations for training:. Eur J Echocardiogr. 2011; 12(10):715-36. DOI: 10.1093/ejechocard/jer181. View

15.

Hebert A, Lavoie P, Giesinger R, Ting J, Finan E, Singh Y . Evolution of Training Guidelines for Echocardiography Performed by the Neonatologist: Toward Hemodynamic Consultation. J Am Soc Echocardiogr. 2019; 32(6):785-790. DOI: 10.1016/j.echo.2019.02.002. View

16.

Kent A, Kecskes Z, Shadbolt B, Falk M . Normative blood pressure data in the early neonatal period. Pediatr Nephrol. 2007; 22(9):1335-41. DOI: 10.1007/s00467-007-0480-8. View

17.

Elmekkawi S, Mansour G, Elsafty M, Hassanin A, Laban M, Elsayed H . Prediction of Fetal Hypertrophic Cardiomyopathy in Diabetic Pregnancies Compared with Postnatal Outcome. Clin Med Insights Womens Health. 2015; 8:39-43. PMC: 4667560. DOI: 10.4137/CMWH.S32825. View

18.

Kozak-Barany A, Jokinen E, Kero P, Tuominen J, Ronnemaa T, Valimaki I . Impaired left ventricular diastolic function in newborn infants of mothers with pregestational or gestational diabetes with good glycemic control. Early Hum Dev. 2004; 77(1-2):13-22. DOI: 10.1016/j.earlhumdev.2003.11.006. View

19.

Vela-Huerta M, Aguilera-Lopez A, Alarcon-Santos S, Amador N, Aldana-Valenzuela C, Heredia A . Cardiopulmonary adaptation in large for gestational age infants of diabetic and nondiabetic mothers. Acta Paediatr. 2007; 96(9):1303-7. DOI: 10.1111/j.1651-2227.2007.00414.x. View

20.

Meyer S, Gottschling S, Baghai A, Wurm D, Gortner L . Arginine-vasopressin in catecholamine-refractory septic versus non-septic shock in extremely low birth weight infants with acute renal injury. Crit Care. 2006; 10(3):R71. PMC: 1550969. DOI: 10.1186/cc4917. View